UR-<wbr/>144 N-<wbr/>(5-<wbr/>hydroxypentyl) metabolite-<wbr/>d<sub>5</sub>

UR-144 N-(5-hydroxypentyl) metabolite-d5

CAT N°: 14375

UR-144 N-(5-hydroxypentyl) metabolite-d5 (Item No. 14375) is intended for use as an internal standard for the quantification of UR-144 N-(5-hydroxypentyl) metabolite by GC- or LC-MS. UR-144 is a potent synthetic cannabinoid (CB) that preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).{20487} UR-144 N-(5-hydroxypentyl) metabolite is an expected phase I metabolite of UR-144, based on the metabolism of similar cannabimimetics.{19353,20170} This metabolite should be detectable in either serum or urine. The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • [1-(5-hydroxypentyl)-1H-indol-3-yl-2,4,5,6,7-d5](2,2,3,3-tetramethylcyclopropyl)-methanone
  • Correlated keywords
    • metabolites UR144 URs 144s 5-OH 5-hydroxyl pentyls metabolites deuteriums deuterateds liquids chromatography LC-MS LC/MS gas GC-MS GC/MS mass spectrometry MS cannabinoids cannabimimetics receptors agonists spices forensics synthetics sciences metabolites CBs serums urine phases 1 2 CB1 CB2 central peripheral mn-001 mn001 mn 001 XLR-11 XLR11 XLR 11 analytical references standards internal quantifications quantifies
  • Product Overview:
    UR-144 N-(5-hydroxypentyl) metabolite-d5 (Item No. 14375) is intended for use as an internal standard for the quantification of UR-144 N-(5-hydroxypentyl) metabolite by GC- or LC-MS. UR-144 is a potent synthetic cannabinoid (CB) that preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).{20487} UR-144 N-(5-hydroxypentyl) metabolite is an expected phase I metabolite of UR-144, based on the metabolism of similar cannabimimetics.{19353,20170} This metabolite should be detectable in either serum or urine. The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.

We also advise you